Medtronic
Technical Monograph / Research Compilation

References

1. Stahle, J. Stahle C., Arenberg I.K. 1978. The incidence of Ménière's 
Disease. Arch Otolaryngol. 104:99-102.

2. Anderson J.P., Harris J.P, Impact of Meniere's Disease on Quality of Life. Otology & Nerotology, 2001; 22:888-894

3. Torok N. 1977. Old and new in Ménière disease. Laryngoscope 87(11): 1870-1877.

4. Gulya A.J., Schuknecht H.F. 1982. Classification of endolymphatic hydrops. Am J Otolaryngol . 3(5): 319-322.

5. Schuknecht H.F. 1975. Pathophysiology of Ménière's disease. Otolaryngol Clin North Am . 8(2): 507-514.

6. Andrews J.C., Bohmer A., Hoffman L.F. 1991. The measurement and manipulation of intralabyrinthine pressure in experimental endolymphatic hydrops. Laryngoscope . 101:661-668.

7. Hallpike C.S., Cairns H. 1938. Observations on the pathology of Ménière's syndrome. J Laryngol Otol 53:625-655.

8. Claes J., Van de Heyning P.H. 1977. Medical treatment of Ménière's disease: A review of literature. Acta Otolaryngol (Stockh). Suppl 526:10-3.

9. Dederding D. 1929. Clinical and experimental examinations in patients suffering from Ménière: Including a study of the problem of bone conduction. Acta Otolarynogol [Suppl] (Stockh) 10(1): 1-156.

10. Furstenberg A C., Lashmet F.H., Lathrop F.D. 1934. Ménière's symptom complex: medical treatment. Ann Otol Rhinol Laryngol 43:1035-1047.

11. Gates G.A. 1999. Innovar treatment for Ménière's disease. Acta Otolaryngol 119:189-193.

12. Thomsen J., Bretlau P., Tos M., Johnsen N.J. 1981. Placebo effect  in surgery for Ménière's disease. A double-blind, placebo-controlled study on endolymphatic sac shunt surgery. Arch Otolaryngol 107:271-277.

13. Silverstein H., Arrada J., Kugler Publications. pp 369-79.

14. Hellstrom S., ödkvist L.M. 1994. Pharmacologic labyrinthectomy. Otolaryngol Clin North Am 27:307-315.

15. LaRouere M J., Zappia J.J., Graham M.D. 1993. Titration streptomycin therapy in Ménière's disease: current concepts. Am J Otol Vol. 14:474-477.

16. Lundgren CEG. Alternobaric vertigo – a diving hazard. 
Br Med J. 1965;2:511-3.

17. Tjernström Ö. 1974. Alternobaric vertigo. An experimental study in man of vertigo due to atmospheric pressure changes. Thesis, Malmö General Hospital. 1974.

18. Ingelstedt S., Ivarsson A., Tjernström ö., Immediate relief of symptoms during acute attacks of Ménière's disease, using a pressure chamber. Acta Otolaryngol Stockh. 1976, 82(5-6): 368-378.

19. Younger R., Longridge N.S., Mekjavic I., Effect of reduced atmospheric pressure on patients with fluctuating hearing loss due to Ménière's disease. J Otolaryngology, 1984, 13: 76-82.

20. Densert O., Carlborg B., Stagg J., Transmission of low frequency pressure steps to the perilymphatic fluid. Acta Otolarygol (Stockh) 1981; 91: 55-64

21. Carlborg B., Densert B., Densert O., Functional patency of the cochlear aqueduct. Ann Oto Rhino Laryngo 1982; 91; 209-215

22. Densert B., Densert O., Erlandsson B., Shepard H., Transmission of square wave pressure pulses through the perilymphatic fluid in cats. Acta Otolaryngol (Stockh) 1986; 102: 186-93.

23. Densert B., Densert O., Erlandsson B., Shepard H. Transmission of complex pressure waves through the perilymphatic fluid in cats. Acta Otolarygol (Stockh) 1986; 102: 403-409

24. Sakikaw Y., Kimura R. Middle ear overpressure treatment of endolymphatic hydrops in guinea pigs. ORL , 1997; 59: 84-90

25. Gibson W.P., Arenberg I.K. Pathophysiologic Theories in the Etiology of Meniere's Disease. Otolaryngol Clin N Am. 1997; 30: 961-7

26. Feijen R.A. et al, Monitoring Inner Ear Pressure Changes in Normal Guinea Pigs Induced by the Meniett 20. Acta Otolaryngol (Stockh). 2000;120:804-9

27. Densert B., Densert O., Arlinger S., Sass K., Ödkvist LM., Immediate effects of middle ear pressure changes on the electrocochleographic recordings in patients with Ménière's Disease: A clinical placebo-controlled study. American Journal of Otology, 1997: 18: 726-33.

28. Ödkvist L.M., Arlinger S., Billermark E., Densert B., Lindholm S., Wallquist J., Effects of middle ear pressure changes on clinical symptoms in patients with Ménière's Disease - a clinical multicenter placebo-controlled study. Acta Otolaryngol (Stockh) 2000; Suppl 543: 99-101.

29. Gates G.A., Green J.D., Intermittent Pressure Therapy of Intractable Meniere's Disease Using the Meniett Device: A Preliminary Report. Laryngoscope, In Publication

30. Densert B., Sass K., Control of symptoms in patients with Ménière's Disease using middle ear applications: Two-years follow-up. Acta Otolaryngologica (Stockh) 2001; 120:5


Medtronic Xomed Headquarters
6743 Southpoint Drive North
Jacksonville, FL 32216-0980
USA 
Internet: www.xomed.com
Toll free: 800-874-5797 
FAX: 800-678-3995
International Telephone Numbers
Australia: 61-2-9879-5999
Benelux: 31-45-566-8000
Canada: 800-268-5346
China: 86-21-50800998
France: 33-470-679800
Germany: 49-211-5293246
Japan: 81-44-540-6359
UK: 44-1454-619555
USA: 904-296-9600

©2003 Medtronic Xomed, Inc. 890103 06.02 2003-141
™ are Trademarks of Medtronic Xomed, Inc.

Back to top

Version 2.15.0
                     Published: January 27, 2004

                    Last Updated: April 11, 2005
                    Important Safety Information! 
     
All articles and graphics copyright © Medtronic Xomed, Inc. 2002 - 2003. All rights reserved. The Meniett® Low-Pressure Pulse Generator can
      only be used with a doctor's prescription. If you would like to order a Meniett device and have a doctor's prescription, click here. Meniett® is 
      a trademark of Medtronic Xomed, Inc. Innovar® is a registered mark of Johnson & Johnson Corp. Dyazide™ is a trademark of 
      GlaxoSmithKline. Privacy Statement | Terms of Use  |  iTonsil.com | LandmarX.com | MedtronicENT.com | MicroFrance.com | SinusInfoCenter.com